Drug intelligence / Profile preview

ginsenoside 20(S)-Rh2

Development stage
Preclinical
Lead developer
China Pharmaceutical University
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

**ginsenoside 20(S)-Rh2** is a dammarane-type triterpenoid saponin and a bioactive component of Panax ginseng and Panax notoginseng. It is present in very low amounts in red ginseng and is mainly recognized for its potent antitumor properties, including apoptosis induction, inhibition of cancer cell proliferation, metastasis, and modulation of tumor cell energy metabolism. Its proposed mechanisms include direct binding and inhibition of Annexin A2 (reducing NF-κB signaling and survival gene expression), inhibition of PI3K/Akt/mTOR and STAT3/c-Myc pathways, enhancement of caspase activation, and modulation of death receptor 5 (DR5) activity. The compound sensitizes cancer cells to TRAIL-induced apoptosis and may enhance efficacy of anticancer agents. Ginsenoside 20(S)-Rh2 also possesses hepatoprotective, cardioprotective, bone density conservation, and antibacterial properties, including the capacity to increase intracellular antibiotic accumulation via inhibition of P-gp and BCRP efflux transporters[1][2][3][4][5][6][8].

Other names
ginsenoside Rh2G-Rh2G-Rh-2G-Rh 220S-ginsenoside Rh220(S)-ginsenoside-Rh2
02

Targets

STAT3 (Signal Transducer and Activator of Transcription 3)ANXA2 (Annexin A2)EGFR (Epidermal growth factor receptor)

Beyond the preview

Go deeper on ginsenoside 20(S)-Rh2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ginsenoside 20(S)-Rh2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call